Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Biomarkers, 2010
    Oxidized DJ-1 as a Biomarker for Parkinson's Disease

    Objective/Rationale
    Mutations in the DJ-1 gene are associated with an early-onset familial form of PD and DJ-1 protein has been shown to be decreased in the CSF of sporadic PD compared to controls. ...

  • Target Validation, 2010
    Pharmacological PHD Inhibition as a Potential PD Neuroprotectant Therapy

    Objective/Rationale
    A growing body of evidence suggests that iron dysregulation may contribute to neurodegeneration associated with Parkinson’s disease (PD). Recent work from our laboratory suggests...

  • Rapid Response Innovation Awards, 2010
    Protecting Innervation: Nmnat1 Gene Therapy for Parkinson's Disease

    Objective/Rationale
    Axonal degeneration is a major pathological hallmark of Parkinson’s disease (PD). Evidence gathered in PD patients indicates that pathology in axons occurs prior to and...

  • Rapid Response Innovation Awards, 2010
    Genetic-epidemiological Confirmation of Top Hits of GWAS of Parkinson Disease: A Large Multi-center Collaborative Study

    Objective/Rationale
    A critical question which is still unresolved in the post GWAS (genome-wide association study) era focuses on the role of non genetic factors conferring either a risk or...

  • Rapid Response Innovation Awards, 2010
    Development of a Progressive Familial Pre-clinical Model of Parkinson's Disease

    Objective/Rationale
    Although a number of genes have been identified that lead to Parkinson’s disease in humans, the scientific community has yet to be able to recapitulate this in pre-clinical...

  • Critical Challenges in PD: Alpha-synuclein Neuroimaging, 2010
    Development and Screening of Contrast Agents for In-vivo Imaging of Parkinson's Disease

    Promising Outcomes of Original Grant:
    The goals of the original grant were to screen a library of compounds to identify leads for non-invasive imaging of PD pathology. We used cell culture models of...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.